Koninklijke DSM Competitors

Basf (OTCMKTS:BASFY) and Koninklijke DSM (OTCMKTS:RDSMY) are both large-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Volatility & Risk

Basf has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Valuation & Earnings

This table compares Basf and Koninklijke DSM's revenue, earnings per share and valuation.

Basf has higher revenue and earnings than Koninklijke DSM. Basf is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Basf pays an annual dividend of $0.70 per share and has a dividend yield of 3.3%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Basf pays out 62.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Basf and Koninklijke DSM's net margins, return on equity and return on assets.

Institutional & Insider Ownership

0.2% of Basf shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Basf and Koninklijke DSM, as reported by MarketBeat.com.

Koninklijke DSM (OTCMKTS:RDSMY) and Asahi Kasei (OTCMKTS:AHKSY) are both large-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Volatility & Risk

Koninklijke DSM has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Asahi Kasei has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Insider and Institutional Ownership

0.1% of Koninklijke DSM shares are held by institutional investors. Comparatively, 0.1% of Asahi Kasei shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Koninklijke DSM and Asahi Kasei's gross revenue, earnings per share (EPS) and valuation.

Asahi Kasei has higher revenue and earnings than Koninklijke DSM. Asahi Kasei is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Asahi Kasei pays an annual dividend of $0.48 per share and has a dividend yield of 2.2%. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Asahi Kasei pays out 27.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Asahi Kasei is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares Koninklijke DSM and Asahi Kasei's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Koninklijke DSM and Asahi Kasei, as provided by MarketBeat.com.

Summary

Asahi Kasei beats Koninklijke DSM on 8 of the 15 factors compared between the two stocks.

FMC (NYSE:FMC) and Koninklijke DSM (OTCMKTS:RDSMY) are both large-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.

Insider and Institutional Ownership

87.4% of FMC shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. 1.0% of FMC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

FMC has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Koninklijke DSM has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

Earnings & Valuation

This table compares FMC and Koninklijke DSM's revenue, earnings per share and valuation.

Koninklijke DSM has higher revenue and earnings than FMC. FMC is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares FMC and Koninklijke DSM's net margins, return on equity and return on assets.

Dividends

FMC pays an annual dividend of $1.92 per share and has a dividend yield of 1.6%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. FMC pays out 31.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. FMC has raised its dividend for 1 consecutive years. FMC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Ratings

This is a breakdown of current ratings and target prices for FMC and Koninklijke DSM, as provided by MarketBeat.

FMC currently has a consensus price target of $129.3333, suggesting a potential upside of 10.87%. Given FMC's stronger consensus rating and higher probable upside, research analysts plainly believe FMC is more favorable than Koninklijke DSM.

Summary

FMC beats Koninklijke DSM on 13 of the 17 factors compared between the two stocks.

Koninklijke DSM (OTCMKTS:RDSMY) and Johnson Matthey (OTCMKTS:JMPLY) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Institutional and Insider Ownership

0.1% of Koninklijke DSM shares are held by institutional investors. Comparatively, 0.0% of Johnson Matthey shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Koninklijke DSM and Johnson Matthey, as reported by MarketBeat.

Dividends

Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Koninklijke DSM and Johnson Matthey's net margins, return on equity and return on assets.

Risk & Volatility

Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Valuation and Earnings

This table compares Koninklijke DSM and Johnson Matthey's gross revenue, earnings per share (EPS) and valuation.

Koninklijke DSM has higher earnings, but lower revenue than Johnson Matthey. Johnson Matthey is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Summary

Koninklijke DSM beats Johnson Matthey on 9 of the 13 factors compared between the two stocks.

Olin (NYSE:OLN) and Koninklijke DSM (OTCMKTS:RDSMY) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Risk and Volatility

Olin has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Profitability

This table compares Olin and Koninklijke DSM's net margins, return on equity and return on assets.

Institutional & Insider Ownership

84.7% of Olin shares are owned by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are owned by institutional investors. 11.7% of Olin shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dividends

Olin pays an annual dividend of $0.80 per share and has a dividend yield of 1.7%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Olin pays out 133.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Olin has increased its dividend for 1 consecutive years. Olin is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation & Earnings

This table compares Olin and Koninklijke DSM's gross revenue, earnings per share (EPS) and valuation.

Koninklijke DSM has higher revenue and earnings than Olin. Koninklijke DSM is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Olin and Koninklijke DSM, as provided by MarketBeat.

Olin currently has a consensus target price of $43.1538, suggesting a potential downside of 6.53%. Given Olin's stronger consensus rating and higher probable upside, analysts clearly believe Olin is more favorable than Koninklijke DSM.

Summary

Koninklijke DSM beats Olin on 9 of the 17 factors compared between the two stocks.

Huntsman (NYSE:HUN) and Koninklijke DSM (OTCMKTS:RDSMY) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Volatility and Risk

Huntsman has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Profitability

This table compares Huntsman and Koninklijke DSM's net margins, return on equity and return on assets.

Insider & Institutional Ownership

77.3% of Huntsman shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. 5.4% of Huntsman shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Huntsman and Koninklijke DSM's revenue, earnings per share and valuation.

Koninklijke DSM has higher revenue and earnings than Huntsman. Huntsman is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Huntsman pays an annual dividend of $0.65 per share and has a dividend yield of 2.1%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Huntsman pays out 42.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 1 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Ratings

This is a summary of current ratings and target prices for Huntsman and Koninklijke DSM, as reported by MarketBeat.

Huntsman presently has a consensus price target of $30.6875, suggesting a potential downside of 0.88%. Given Huntsman's stronger consensus rating and higher possible upside, analysts plainly believe Huntsman is more favorable than Koninklijke DSM.

Summary

Huntsman beats Koninklijke DSM on 11 of the 17 factors compared between the two stocks.